Number of Swiss patients on cancer meds SUDDENLY rose dramatically in 2021-2022. What could it be?

Swiss health economist prof. dr. Konstantin Beck (University of Lucerne) [1] discusses data provided by major Swiss health insurer Helsana [2] about the number of their patients who receive cancer drugs. The latest update has been published on November 30th, 2023.

The average of the number from 2013-2020 is 92 451. In 2022, this number of Helsana insured who were on cancer drugs SUDDENLY increased to at least 152 000, which is an increase of 64%. The increase is 94% compared to 2017.

Mirrored - frankploegman